Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients

Clinical Hemorheology and Microcirculation

Volumn 35, Issue 1-2, 2006, Pages 175-181

  Mannini, Lucia ^a   Marcucci, Rossella ^a   Paniccia, Rita ^a   Antonucci, Emilia ^a   Giglioli, Cristina ^a   Valente, Serafina ^a   Gori, Anna Maria ^a   Prisco, Domenico ^a   Gensini, Gian Franco ^a   Abbate, Rosanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ACUTE HEART INFARCTION; ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; ERYTHROCYTE DEFORMABILITY; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MALE; PLASMA VISCOSITY; POPULATION RESEARCH; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ASPIRIN; BLEEDING TIME; BLOOD VISCOSITY; DRUG RESISTANCE; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMORHEOLOGY; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; THROMBOSIS; TICLOPIDINE;

EID: 33746444276     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. P.A.M.M. Aarts, P.A. Bolhuis, K.S. Sakariassen, R.M. Heethaar and J.J. Sixma, Red blood cells size is important for adherence of blood platelets to artery subendothelium, Blood 62 (1983), 214-220.
2. P.A.M.M. Aarts, R.M. Heethaar and J.J. Sixma, Red blood cell deformability influences platelet-vessel wall interaction in flowing blood, Blood 64 (1984), 1228-1233.
3. S.E. Akopov, G.S. Grigorian and E.S. Gabrielian, Dose-dependent aspirin hydrolysis and platelet aggregation in patients with atherosclerosis, J. Clin. Pharmacol. 32 (1992), 133-135.
4. Antiplatelet Trialists' Collaboration, Collaborative overview of randomized trials of platelet therapy - I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ 308 (1994), 81-106.
5. Y.Y. Bilto, Rheological action of aspirin on human erythrocytes, Clin. Hemorheol. Microcirc. 20 (1999), 159-165.
6. J. Bozzo, M.R. Hernandez and A.Ordinas, Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin, Cardiovasc. Res. 30 (1995), 725-730.
7. M.R. Buchanan and S.J. Brister, Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically, Can. J. Cardiol. 3 (1995), 221-227.
8. G. Ciuffetti, R. Lombardini, M. Pirro, G. Lupattelli and E. Mannarino, Clopidogrel: hemorheological effects in subjects with subclinical atherosclerosis, Clin. Hemorheol. Microcirc. 25 (2001), 31-39.
9. H. Demiroglu, The importance of erythrocyte aggregation in blood rheology: consideration on the pathophysiology of thrombotic disorders, Blood 89 (1997), 4236.
10. J.A. Dormandy, Blood viscosity and red cell deformability, in: Methods in Angiology, Martinus Nijoff, 1980, pp. 211-216.
11. E.J. Favaloro, G. Kershaw, M. Bukuya, M. Hertzberg and J. Koutts, Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies, Haemophilia 7 (2001), 180-189.
12. M.I. Furman, S.E. Benoit, M.R. Barnard, C.R. Valeri, M.L. Borbone, R.C. Becker, H.B. Hechtman and A.D. Michelson, Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease, J. Am. Coll. Cardiol. 31 (1998), 352-358.
13. P. Harrison, In vitro measurement of hig-shear platelet adhesion and aggregation by the PEA-100, Methods Mol. Biol. 272 (2004), 215-223.
14. P. Harrison, M. Robinson, R. Liesner, K. Khair, H. Cohen, I. Mackie and S. Machin, The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction, Clin. Lab. Haem. 24 (2002), 225-232.
15. G.A. Higgs, J.A. Salmon, B. Henderson and J.R. Vane, Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cycloxygenase and anti-inflammatory activity, Proc. Natl. Acad. Sci. 84 (1987), 1417-1420.
16. M. Hoffman, A. Blum, R. Baruch, E. Kaplan and M. Benjamin, Leukocytes and coronary artery disease, Atherosclerosis 172 (2004), 1-6.
17. M. Homoncik, B. Jilma, B. Eichelberger and S. Panzer, Inhibitory activity of aspirin on von Willebrand factor-induced platelet aggregation, Thromb. Res. 99 (2000), 461-466.
18. International Committee for Standardization in Haematology: Guidelines for measurement of blood viscosity and erythrocyte deformability, Clin. Hemorheol. 6 (1986), 439-453.
19. B. Jilma, Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction, J. Lab. Clin. Med. 138 (2001), 152-163.
20. J.G. Jones, R.A. Adams, A.M. Cook and S.A. Evans, Examination of a rheological profile for blood using micropore filters, Br. J. Haematol. 104 (1999), 100-107.
21. E. Larsen, A. Celi and G.E. Gilbert, PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes, Cell 59 (1989), 305-312.
22. N. Lin, H. Hu and P. Hjemdahl, Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry, Thromb. Res. 111 (2003), 165-170.
23. S.A. McKee, D.C. Sane and E.N. Deliargyris, Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance, Thromb. Haemost. 88 (2002), 711-715.
24. W. Palinski, A. Torsellini and E. Doni, Influence of platelet activation of erythrocyte deformability, Thromb. Haemost. 49 (1983), 84-86.
25. S. Ramakrishnan, R. Grebe, M. Singh and H. Schmid-Schönbein, Evaluation of hemorheological risk factor profile in plasmacytoma patients, Clin. Hemorheol. 20 (1999), 11-19.
26. R.C. Reimers, S.P. Sutera and J.H. Joist, Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms, Blood 64 (1984), 1200-1206.
27. J. Sarma, C.A. Laan, A. Alam, A. Jha, K.A.A. Fox and I. Dransfield, Increased platelet binding to circulating monocytes in acute coronary syndromes, Circulation 105 (2002), 2166-2171.